Health News
FDA to expedite review of Teva drug for movement disorder2/28/2017 5:07:58 PMTEL AVIV - Israel-based Teva Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration (FDA) has granted "priority review" for its SD-809 drug to treat tardive dyskinesia with a target date for approval by Aug. 30.Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study2/28/2017 5:32:06 PM - Patients with relapsed multiple myeloma treated with Amgen Inc's Kyprolis lived more than seven months longer than those who received Takeda Pharmaceutical Co's Velcade, according to data from a late-stage study released by Amgen on Tuesday.Accera's Alzheimer's trial fails, in yet another setback for disease2/28/2017 5:06:40 PM - Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective treatment for the rampant mind-wasting disease.India issues fresh antibiotic guidelines to tackle superbug menace2/28/2017 5:02:05 PMMUMBAI - India, one of the world's biggest consumers of antibiotics, has issued new national guidelines on their use as part of a drive to fight the rise of drug-resistant superbugs.Merck KGaA, Pfizer get priority review for bladder cancer drug2/28/2017 4:12:42 PMFRANKFURT - German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer.Kite Pharma's cancer drug clears main goal in study2/28/2017 5:07:03 PM - Kite Pharma Inc said on Tuesday its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, meeting the main goal of a key study.Business groups, once tobacco-friendly, switch sides in fight2/28/2017 3:33:58 PMNEW YORK - The local chamber of commerce is usually a reliable ally in battles against regulation. But when it comes to smoking rules, many business groups have decided they would rather switch than fight.Roche to start new trial of AC Immune drug against Alzheimer's2/28/2017 11:47:52 AMZURICH - Roche is starting a second late-stage trial of investigational Alzheimer's drug crenezumab that it is developing with Swiss biotech AC Immune, shrugging off failures of similar drugs against the memory-robbing disease.Grain traders prepping fish oil substitutes for aquaculture, health fads2/28/2017 9:45:41 AM - The world's top agricultural traders and biotechnology firms are finding novel ways to make fish oil substitutes from grains and algae as they seek to cash in on consumer health fads that have led to a scarcity of the fatty acids commonly found in fish.Trump seeks help of insurers to smooth Obamacare transition2/28/2017 2:30:37 AMNEW YORK/WASHINGTON - President Donald Trump sought on Monday to bring the nation's largest insurance companies on board with his plans to overhaul Obamacare, saying their help was needed to deliver a smooth transition to the Republicans' new plan.